Selection from HEOR Bibliography
| Search criteria | ||||
| Metabolic Disorders |
||||
| CO71 Investigating the Secondary Care System Burden of Glycogen Storage Disease Type IA (GSDIA) Using the HES Database | ||||
| E Kruger S Chavda RN Gupta V Valayannopoulos | ||||
| Ultragenyx Pharmaceutical Inc., Novato, CA, USA IQVIA, London, UK Ultragenyx Pharmaceutical Inc., Cambridge, MA, USA | ||||
| Kruger, E et al. Value in Health, Volume 25, Issue 7, S317 |
||||
| , Abstract, Article | ||||
| , England | ||||
| Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(22)00370-9/pdf#%20 | ||||
| Condition | Year | Language | Analysis type | |
| , Metabolic Disorders , Rare disease, Rare Diseases | 2022 | English | , Burden of illness, clinical setting: Secondary care, Quality of life | |
| Impact of lurasidone and other antipsychotics on body weight: real-world, retrospective, comparative study of 15,323 adults with schizophrenia | ||||
| Pochiero I, Calisti F, Comandini A, Del Vecchio A, Costamagna I, Rosignoli MT, Cattaneo A, Nunna S, Peduto I, Heiman F, Chang H, Chen C, Correll C | ||||
| Pochiero I: Angelini Regulatory, Research & Development, Angelini Pharma S.p.A., Rome, Italy; Peduto I and Heiman F: IQVIA Solutions Italy Srl, RWS | ||||
| Int J Gen Med. 2021 Jul 31;14:4081-4094. doi: 10.2147/IJGM.S320611. PMID: 34366678; PMCID: PMC8336993. |
||||
| , Article | ||||
| , Italy, USA | ||||
| Abstract: https://www.dovepress.com/impact-of-lurasidone-and-other-antipsychotics-on-body-weight-real-worl-peer-reviewed-fulltext-article-IJGM | ||||
| Condition | Year | Language | Analysis type | |
| , Mental health, Metabolic Disorders | 2021 | English | , Clinical setting: Primary care, Epidemiological study, Retrospective database analysis | |
| The Impact of Label Extensions on the Reimbursed Price of Pharmaceutical Products Assessed According to §35A SGB V in Germany Oncological and Metabolic Diseases | ||||
| Schmalhofer C, Eheberg D, Tremmel M, Bocuk D, Roxlau T, Antoni B, Bonduelle D | ||||
| IQVIA Commercial GmbH & Co. OHG, Munich, Germany | ||||
| , Abstract | ||||
| , Germany | ||||
| Condition | Year | Language | Analysis type | |
| , Health economics, Health policy, Metabolic Disorders , Oncology, Pricing and reimbursement | 2018 | English | , Cost analysis, Pricing & Reimbursement | |
| Frequency of Blood Pressure and Estimated Glomerular Filtration Rate Testing in Type 2 Diabetes Mellitus: A Retrospective Study with 43,509 Patients | ||||
| Kostev K, Lucas A, Jacob L | ||||
| EXP CLIN ENDOCRINOL DIABETES. 2018 MAR 12. |
||||
| , Article | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes, Metabolic Disorders , Vascular disease | 2018 | English | , Retrospective cohort analysis | |
| LBP-528 – Incidence and prevalence of recorded non-alcoholic fatty liver disease in four large European primary care databases covering 21.9 million adults | ||||
| "M. Alexander, K. Loomis, J. Fairburn-Beech, J. van der Lei, T. Duarte-Salles, D. Ansell, A. Pasqua, P. Rijnbeek, P. Avillach, S. Kendrick, D. Waterworth, N. Sattar, W. Alazawi" | ||||
| EMIF group | ||||
| Journal of Hepatology ; Volume 66, Issue 1, Supplement |
||||
| , Abstract | ||||
| , UK | ||||
| Condition | Year | Language | Analysis type | |
| , Metabolic Disorders | 2017 | English | , Retrospective database analysis | |
| LBP-528 – Incidence and prevalence of recorded non-alcoholic fatty liver disease in four large European primary care databases covering 21.9 million adults | ||||
| M. Alexander, K. Loomis, J. Fairburn-Beech, J. van der Lei, T. Duarte-Salles, D. Ansell, A. Pasqua, P. Rijnbeek, P. Avillach, S. Kendrick, D. Waterworth, N. Sattar, W. Alazawi | ||||
| EMIF group | ||||
| , Article | ||||
| , UK | ||||
| Condition | Year | Language | Analysis type | |
| , Metabolic Disorders | 2017 | English | , Retrospective database analysis | |
| Trends in the Diagnosis of Vitamin D Deficiency | ||||
| Emre Basatemur, MBBS, MRCPCH, a Laura Horsfall, PhD, b Louise Marston, PhD, b Greta Rait, MD, b Alastair Sutcliffe, PhDa | ||||
| University College London | ||||
| , Article | ||||
| , UK | ||||
| Condition | Year | Language | Analysis type | |
| , Metabolic Disorders | 2017 | English | , Retrospective database analysis | |
| Prevalence of high-risk cardiovascular patients with therapy-resistant hypercholesterolemia | ||||
| Kostev K, Parhofen K, Dippel FW | ||||
| Cardiovasc Endocrinol. 2017 Jun;6(2):81-85. doi: 10.1097/XCE.0000000000000098. Epub 2016 Oct 14. |
||||
| , Article | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease, Metabolic Disorders | 2017 | English | , Epidemiological study | |
| Trends in the Diagnosis of Vitamin D Deficiency | ||||
| Emre Basatemur, MBBS, MRCPCH, a Laura Horsfall, PhD, b Louise Marston, PhD, b Greta Rait, MD, b Alastair Sutcliffe, PhDa | ||||
| University College London | ||||
| , Article | ||||
| , UK | ||||
| Condition | Year | Language | Analysis type | |
| , Metabolic Disorders | 2017 | English | , Retrospective database analysis | |
| Incidence and prevalence of recorded non-alcoholic fatty liver disease in four large European primary care databases covering 21.9 million adults | ||||
| Alexander M, Loomis K, Fairburn-Beech J, van der Lei J, Duarte-Salles T, Ansell D, Pasqua A, Rijnbeek P, Avillach P, Kendrick S, Waterworth D, Sattar N & Alazawi W | ||||
| EMIF group | ||||
| Journal of Hepatology |
||||
| , Abstract, Poster | ||||
| , UK | ||||
| Condition | Year | Language | Analysis type | |
| , Metabolic Disorders | 2017 | English | , Retrospective database analysis | |
| Clinical Implications of Switching Lipid Lowering Treatment from Rosuvastatin to Other Agents in Primary Care. | ||||
| Colivicchi F1, Gulizia MM2, Franzini L3, Imperoli G4, Castello L1, Aiello A1, Ripellino C5, Cataldo N5. | ||||
| 1 Cardiology Division, S. Filippo Neri Hospital, ASL Roma 1, Rome, Italy 2 Cardiology Division, Garibaldi Nesima Hospital,Catania, Italy 3 AstraZeneca S.p.A., Milan, Italy 4 Internal Medicine Division, S. Filippo Neri Hospital, ASL Roma 1, Rome, Italy 5 IMS Health Information Solutions Italy S.r.l., Milan, Italy | ||||
| Advances in Therapy, 2016, [Epub ahead of print]. |
||||
| , Manuscript in preparation | ||||
| , Italy | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pubmed/?term=Clinical+Implications+of+Switching+Lipid+Lowering+Treatment+from+Rosuvastatin+to+Other+Agents+in+Primary+Care | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease, Metabolic Disorders | 2016 | English | , Clinical setting: Primary care, Database Study, Epidemiological study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis | |
| Rosuvastatin: switching treatment and clinical implications in primary care. | ||||
| Heiman F1, Ripellino C1, Colivicchi F2. | ||||
| 1 IMS Health Information Solutions Italy Srl 2 Cardiology Division, S. Filippo Neri Hospital, ASL Roma 1, Rome, Italy. | ||||
| , Poster | ||||
| , Italy | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease, Metabolic Disorders | 2016 | English | , Clinical setting: Primary care, Database Study, Epidemiological study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis | |
| Changes in HbA1c, Body Weight, and Systolic Blood Pressure in Type 2 Diabetes Patients Initiating Dapagliflozin Therapy: A Primary Care Database Study | ||||
| Scheerer M, Rist R, Proske O, Meng A, Kostev K | ||||
| Diabetes Metab Syndr Obes. 2016 Oct 31;9:337-345. |
||||
| , Article | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease, Diabetes, Metabolic Disorders | 2016 | English | , Database Study | |
| Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis. | ||||
| Morlock R, Chevalier P, Horne L, Nuevo J, Storgard C, Aiyer L, Hines DM, Ansolabehere X, Nyberg F. | ||||
| Rheumatol Ther. 2016 Jun;3(1):53-75. |
||||
| , Article | ||||
| , France, Germany, UK, USA | ||||
| Condition | Year | Language | Analysis type | |
| , Health economics, Health policy, Metabolic Disorders , Public Health | 2016 | English | , Retrospective cohort analysis | |
| Adherence to GLP-1 Receptor Agonist Therapy Administered by Once-Daily or Once-Weekly Injection in Type 2 Diabetes Patients in Germany | ||||
| Qiao Q, Grandy S, Ouwens M, Kostev K | ||||
| Diabetes Metab Syndr Obes. 2016 Jun 28;9:201-5 |
||||
| , Article | ||||
| , Germany | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes, Metabolic Disorders | 2016 | English | ||
| Microvascular Outcomes in Patients with Type 2 Diabetes Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Study Using German Electronic Medical Records. | ||||
| Kolaczynski WM, Hankins M, Ong SH, Richter H, Clemens A, Toussi M. | ||||
| Diabetes Ther. 2016 Sep;7(3):483-96. doi: 10.1007/s13300-016-0177-8. |
||||
| , Article | ||||
| , Germany | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease, Diabetes, Metabolic Disorders | 2016 | English | , Retrospective database analysis | |
| The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain. | ||||
| Maina G1, Ripellino C2 | ||||
| 1 Department of Neurosciences, University of Torino, Torino, 2 CSD Medical Research S.R.L, Milan, Italy | ||||
| Expert Opin Drug Saf. 2014 Sep;13(9):1149-54. doi: 10.1517/14740338.2014.943732. Epub 2014 Jul 18. |
||||
| , Article | ||||
| , Italy, Spain | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25036458 | ||||
| Condition | Year | Language | Analysis type | |
| , Mental health, Metabolic Disorders | 2014 | English | , Retrospective database analysis | |
| Diabète de type 2 : quels objectifs thérapeutiques selon les nouvelles recommandations de l’HAS ? Analyse de 6 680 patients suivis par des médecins [Type 2 diabetes: which therapeutic objectives according to the new recommendations of the HAS? Analysis of 6,680 patients followed by doctors]. | ||||
| Larger E1, Ansolabehere X2, Grandfils N2, Le Jeunne P2 | ||||
| 1 GH Cochin Hôtel-Dieu, Paris 2 IMS Health HEOR, La Défense | ||||
| Congrès annuel de la Société Francophone du Diabète (SFD). 11-14 mars 2014 Paris |
||||
| , Poster | ||||
| , France | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes, Endocrinology, Metabolic Disorders | 2014 | French | , Retrospective database analysis | |
| Achievement of lipoprotein goals among patients with metabolic syndrome at high cardiovascular risk across Europe. The EURIKA study. | ||||
| Banegas JR1, López-GarcÃa E, Dallongeville J, Guallar E, Halcox JP, Borghi C, Massó-González EL, Sazova O, Perk J, Steg PG, De Backer G, RodrÃguez-Artalejo F. | ||||
| 1Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid/IdiPAZ, CIBER of Epidemiology and Public Health, Madrid, Spain | ||||
| Int J Cardiol. 2013 Jun 5;166(1):210-4. doi: 10.1016/j.ijcard.2011.10.094. Epub 2011 Nov 5 |
||||
| , Article | ||||
| , Europe | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22056474 | ||||
| Condition | Year | Language | Analysis type | |
| , Metabolic Disorders | 2013 | English | , Prospective study | |
| Gilbert's syndrome and the risk of death: a population-based cohort study. | ||||
| Horsfall LJ, Nazareth I, Pereira SP & Petersen I | ||||
| UCL Research Department of Primary Care and Population Health | ||||
| J Gastroenterol Hepatol. 2013 Oct;28(10):1643-7. doi: 10.1111/jgh.12279. |
||||
| , Article | ||||
| , UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23701650 | ||||
| Condition | Year | Language | Analysis type | |
| , Hematology, Metabolic Disorders | 2013 | English | , Retrospective database analysis | |
| Multilevel Analysis of the Influence of Patients’ and General Practitioners’ Characteristics on Patented Versus Multiple-Sourced Statin Prescribing in France | ||||
| Pichetti S(1), Sermet C(1), Godman B(2,3,4), Campbell SM(5), Gustafsson LL(2). | ||||
| IRDES(1),universités Glasgow(3), Liverpool(4), Manchester(5), Stockholm(2) | ||||
| Appl Health Econ Health Policy. 2013 Jun;11(3):205-18. |
||||
| , Article | ||||
| Condition | Year | Language | Analysis type | |
| , Metabolic Disorders | 2013 | English | ||
| An observational study of the initial management of hypothyroidism in France: the ORCHIDÉE study. | ||||
| Delemer B, Aubert JP, Nys P, Landron F, Bouée S. | ||||
| Eur J Endocrinol. 2012 Dec;167(6):817-23. doi: 10.1530/EJE-11-1041. Epub 2012 Oct 3. |
||||
| , Article | ||||
| , France | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23034782 | ||||
| Condition | Year | Language | Analysis type | |
| , Metabolic Disorders | 2012 | English | ||
| Severe hypertriglyceridaemia in patients treated with lipid-modifying agents. | ||||
| Désaméricq G1, Van Ganse E1, Schwalm MS2, Bourke A3, Moulin P4. | ||||
| 1Unité de pharmaco-épidémiologie, faculté d’odontologie UCBL, CHU de Lyon, 69372 Lyon, France 2Cegedim Strategic Data, 92100 Boulogne-Billancourt, France 3The Health Improvement Network, SW8 3QJ London, UK 4Université de Lyon, 69003 Lyon, France Inserm, U870, IFR62, 69008 Lyon, France Inra, UMR1235, 69008 Lyon, France INSA-Lyon, RMND, 69621 Villeurbanne, France Hospices Civils de Lyon, 69008 Lyon, France | ||||
| Diabetes & Metabolism Volume 38, n° 3 pages 277-279 (juin 2012) |
||||
| , Article | ||||
| , Belgium, France, Germany, Italy, UK | ||||
| Abstract: http://www.em-consulte.com/en/article/735594 | ||||
| Condition | Year | Language | Analysis type | |
| , Endocrinology, Metabolic Disorders , Vascular disease | 2012 | English | , Retrospective database analysis | |
| Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA). | ||||
| Pettersson B, Ambegaonkar B, Sazonov V, Martinell M, Stålhammar J, Wändell P. | ||||
| IMS Health, Stockholm. (Formally Pygargus) | ||||
| BMC Public Health. 2010 Nov 29;10:737. doi: 10.1186/1471-2458-10-737. |
||||
| , Article | ||||
| , Sweden | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21114824 | ||||
| Condition | Year | Language | Analysis type | |
| , Metabolic Disorders | 2010 | English | , Observational study | |
| Characteristics and LDL-C Therapeutic Objectives of Patients Receiving Unusual Lipid-Modifying Therapy Regimen | ||||
| Desamericq G, Laforest L, Schwalm MS, Bourke A, Broquet M, Van Ganse E & Moulin P | ||||
| Cegedim | ||||
| ICPE 2010 Pharmacoepidemiology and Drug Safety (19): S1-S347 |
||||
| , Abstract, Poster | ||||
| , France, UK | ||||
| Abstract: https://www.yumpu.com/en/document/view/5337032/poster-session-international-society-for-pharmacoepidemiology/13 | ||||
| Condition | Year | Language | Analysis type | |
| , Endocrinology, Metabolic Disorders , Miscellaneous | 2010 | English | , Retrospective database analysis | |
| Lo studio Primula in Italia. | ||||
| Ambegaonkar BM1, Heiman F2, Soro M3, Sazonov V1. | ||||
| 1 Merck and Co., Inc., Whitehouse Station, NJ, USA, 2 Cegedim Strategic Data, 3 MSD Italy | ||||
| Care Online. CARE 6, 2009. Pag 15-16. |
||||
| , Online article | ||||
| , Italy | ||||
| Abstract: http://careonline.it/wp-content/uploads/2008/08/care_6_09.pdf | ||||
| Condition | Year | Language | Analysis type | |
| , Metabolic Disorders | 2009 | Italian | , Retrospective database analysis | |
| Comparison of prescription patterns of statins in primary care in five European countries: results from the LIPIDE observational survey | ||||
| Desamericq G, Laforest L, Schwalm MS, Moulin P, Michel E, Eteve C, et al | ||||
| ICPE/ISPE, Providence. 2009 |
||||
| , Article | ||||
| , France | ||||
| Condition | Year | Language | Analysis type | |
| , Endocrinology, Metabolic Disorders | 2009 | English | , Retrospective database analysis | |
| Can the relationship between age and cholesterol levels indicate effectiveness of lipid lowering therapy in primary care? France, Germany, Italy and UK | ||||
| Blak BT, Hards M, Maguire A & Schwalm MS | ||||
| Cegedim | ||||
| ISPOR Orlando, USA Value in Health 12(3):A142-A143 |
||||
| , Abstract, Poster | ||||
| , France, Germany, Italy, UK | ||||
| Abstract: https://www.infona.pl/resource/bwmeta1.element.elsevier-ef0c58f0-1c99-3554-8596-1bce21118531 | ||||
| Condition | Year | Language | Analysis type | |
| , Endocrinology, Metabolic Disorders | 2009 | English | , Retrospective database analysis | |
| LDL-C goal attainment according to prescribed lipid-lowering therapy: results from the LIPIDE European survey | ||||
| Desamericq G, Laforest L, Schwalm MS, Moulin P, Michel E, Eteve C, et al | ||||
| Université Paris Est, Faculté de Médecine, Créteil, France; | ||||
| ICPE/ISPE, Providence. 2009 |
||||
| , Article | ||||
| , France | ||||
| Condition | Year | Language | Analysis type | |
| , Endocrinology, Metabolic Disorders | 2009 | English | , Retrospective database analysis | |
| . Prise en charge des patients dyslipidémiques dans cinq pays européens: Résultats préliminaires de l’étude LIPIDE. | ||||
| Desamericq G, Laforest L, Schwalm MS, Moulin P, Michel E, Eteve C, et al. | ||||
| Université Paris Est, Faculté de Médecine, Créteil, France; | ||||
| ADELF, Paris. 2009. [French] |
||||
| , Article | ||||
| , France | ||||
| Condition | Year | Language | Analysis type | |
| , Endocrinology, Metabolic Disorders | 2009 | English | , Retrospective database analysis | |